Furthermore, the combined deficiency of these 3 receptor-ligand interactions led to a ~ 90% decrease in atherosclerosis burden (23), with the major fraction due to the loss of CCR2-CCL2 mediated monocyte migration into plaques (24, 25). This evidence concerns the gene CCL2 and atherosclerosis.